About AABB

Our Association's strength is the diversity of our membership, which comprises the full breadth of the blood and cellular therapy community. Ensuring that members across the spectrum of disciplines are connected and sharing their expertise is instrumental in advancing the field. AABB is committed to:

• Increasing engagement across our community.
• Leveraging our community’s diverse expertise and perspectives.
• Supporting research and communicating advancements in the field.

Promoting a strong blood system and adequate blood supply is essential for health care and is paramount to the work of AABB's members. Ensuring the security of the blood supply is a key priority for our Association. AABB is committed to:

• Raising awareness of the lifesaving value of transfusions and of the expert community that makes these therapies possible.
• Advocating for our diverse stakeholder base to advance a system that supports the availability of blood.
• Promoting a regulatory environment that drives progress and supports blood availability and safety.

Cellular therapies and emerging biotherapies represent the potential for new treatments that can transform patient care. AABB and its members are integral to advancing this dynamic field. AABB is committed to:

• Strengthening the safety and quality of biotherapies by leveraging the expertise of the transfusion medicine and cellular therapies community.
• Fostering the development, manufacturing and delivery of new biotherapies, including cord blood and emerging cellular derived therapies.

AABB's priority is to advance optimal donor safety and patient care. This emphasis is apparent through our accreditation and educational programs, which demonstrate our unwavering focus on quality, our commitment to lifelong learning, and our dedication to training tomorrow’s workforce. AABB is committed to:

• Being the partner of choice for driving quality, safety, innovation and best practices throughout the world.
• Cultivating a well-trained workforce prepared to support the field of transfusion medicine and biotherapies.
• Championing evidence-based clinical practices to improve patient and donor outcomes.